Drug Shortage Report for AMIKACIN SULFATE INJECTION
| Report ID | 129150 |
| Drug Identification Number | 02486717 |
| Brand name | AMIKACIN SULFATE INJECTION |
| Common or Proper name | Amikacin Sulfate Injection |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | AMIKACIN |
| Strength(s) | 250MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10 x 2mL vial / fiole |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2020-10-23 |
| Estimated end date | 2021-04-06 |
| Actual end date | 2021-04-12 |
| Shortage status | Resolved |
| Updated date | 2021-04-26 |
| Company comments | Demand on the market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-04-26 | French | Compare |
| v5 | 2021-04-26 | English | Compare |
| v4 | 2021-02-25 | French | Compare |
| v3 | 2021-02-25 | English | Compare |
| v2 | 2020-11-30 | French | Compare |
| v1 | 2020-11-30 | English | Compare |
Showing 1 to 6 of 6